Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019

Ravindra Ganesh, Lindsey M. Philpot, Dennis M. Bierle, Ryan J. Anderson, Lori L. Arndt, Richard F. Arndt, Tracy L. Culbertson, Molly J. Destro Borgen, Sara N. Hanson, Brian D. Kennedy, Brian B. Kottke, Jennifer J. Larsen, Priya Ramar, Jordan K. Rosedahl, Maria Teresa Seville, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, Caroline G. Wilker, Raymund R. Razonable

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019'. Together they form a unique fingerprint.

Medicine & Life Sciences